Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Fostering drug discovery and development in Africa

Nature Medicine volume 28, pages 1523–1526 (2022)Cite this article

Subjects

The H3D Centre is a South African-based academic translational research unit that has had many successes and could provide a much-needed model for drug discovery and development in Africa.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Pipeline of infectious disease drug discovery.
Fig. 2: Key partnerships for drug discovery at the H3D Centre.

References

  1. Tegally, H. et al. Nature 592, 438–443 (2021).

    Article  CAS  Google Scholar 

  2. Keeton, R. et al. Nature 603, 488–492 (2022).

    Article  CAS  Google Scholar 

  3. Nordling, L. Nat. Med. 19, 803–806 (2013).

    Article  CAS  Google Scholar 

  4. Aldridge, B. B. et al. Nat. Med. 27, 1333–1337 (2021).

    Article  CAS  Google Scholar 

  5. Yang, T. et al. Trends Parasitol. 37, 493–507 (2021).

    Article  CAS  Google Scholar 

  6. Le Manach, C. et al. J. Med. Chem. 64, 2291–2309 (2021).

    Article  Google Scholar 

  7. Singh, V. & Chibale, K. Acc. Chem. Res. 54, 2361–2376 (2021).

    Article  CAS  Google Scholar 

  8. Reader, J. et al. Nat. Commun. 12, 269 (2021).

    Article  CAS  Google Scholar 

  9. Sinxadi, P. et al. Antimicrob. Agents Chemother. 64, e01896–19 (2020).

    Article  CAS  Google Scholar 

  10. Brunchswig, C. et al. Antimicrob. Agents Chemother. 62, e00012–18 (2018).

    Google Scholar 

  11. Nchinda, A. T. et al. J. Med. Chem. 61, 4213–4227 (2018).

    Article  CAS  Google Scholar 

  12. Paquet, T. et al. Sci. Transl. Med. 9, eaad9735 (2017).

    Article  Google Scholar 

  13. Okombo, J. & Chibale, K. Acc. Chem. Res. 50, 1606–1616 (2017).

    Article  CAS  Google Scholar 

  14. International Federation of Pharmaceutical Manufacturers and Associations. https://www.ifpma.org/wp-content/uploads/2021/09/H3D-IFPMA-Partnership.pdf (accessed April 2022).

  15. Merck KGaA. https://www.merckgroup.com/en/news/partnership-uct-mmv-19-04-2018.html (accessed April 2022).

  16. Johnson & Johnson. https://www.jnj.com/johnson-johnson-launches-next-satellite-center-for-global-health-discovery-at-holistic-drug-discovery-and-development-centre-university-of-cape-town-focused-on-antimicrobial-resistance-amr (accessed May 2022).

  17. Mills, E. J. et al. BMJ 343, d7031 (2011).

    Article  Google Scholar 

  18. Bizcommunity. https://www.bizcommunity.com/Article/196/323/192566.html (accessed April 2022).

  19. J. C. Flowers Foundation. https://www.jcflowersfoundation.org/isdell-flowers-cross-border-malaria-initiative.html (accessed May 2022).

  20. African Medicines Agency (AMA). https://www.nepad.org/microsite/african-medicines-agency-ama (accessed May 2022).

  21. Sehmi, K. et al. Front. Med. Technol. 4, 810456 (2022).

    Article  Google Scholar 

Download references

Acknowledgements

The authors thank the University of Cape Town, the South African government (Department of Science and Innovation, Technology Innovation Agency, South African Medical Research Council, Department of Trade and Industry), Wolfson Foundation, Garfield Weston Foundation, Novartis, Medicines for Malaria Venture, Bill & Melinda Gates Foundation, Merck KGaA, Celgene, Royal Society, Global Challenges Research Fund, Newton Fund, Merck & Co Inc., US National Institutes of Health, Janssen Pharmaceutica N.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson (Janssen), and Neville Isdell.

Author information

Authors and Affiliations

  1. Holistic Drug Discovery and Development (H3D) Centre, University of Cape Town, Rondebosch, South Africa

    Susan Winks, John G. Woodland & Kelly Chibale

  2. Division of Clinical Pharmacology, University of Cape Town, Observatory, South Africa

    Goonaseelan ‘Colin’ Pillai

  3. CP+ Associates GmbH, Basel, Switzerland

    Goonaseelan ‘Colin’ Pillai

  4. South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa

    Kelly Chibale

Authors
  1. Susan Winks
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John G. Woodland
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Goonaseelan ‘Colin’ Pillai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kelly Chibale
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.C. designed the content and flow of the paper. S.W. and J.G.W. collected the necessary information and data. S.W., J.G.W., G.C.P. and K.C. wrote the paper.

Corresponding author

Correspondence to Kelly Chibale.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Winks, S., Woodland, J.G., Pillai, G.‘. et al. Fostering drug discovery and development in Africa. Nat Med 28, 1523–1526 (2022). https://doi.org/10.1038/s41591-022-01885-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41591-022-01885-1

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing